Studies based on transgenic PiZ mice or immortalized cell lines engineered to express the human mutant Z AAT allele or on primary human hepatocytes have provided significant insights into the pathogenesis of AATD-associated liver disease. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.